Malnutrition
Methodology & AI Transparency ⓘ
Malnutrition Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: What is malnutrition? Malnutrition means that your body isn't getting enough calories or the right balance of nutrients to stay healthy.
- 2 Real-world patient consensus: Diagnostic registry E63.9: Malnutrition is managed within Weight & Metabolism.
- 3 Typical cash cost range: Primary evaluation for Malnutrition incorporates fasting cardiometabolic panels [Malnutrition E63.9] and symptom diary review.
- 4 Top reported side effects / signs: Objective lab/clinical target for Malnutrition: HOMA-IR Insulin Resistance in Malnutrition (E63.9: Index) (< 1.4 (E63.9)) and ALT & Fasting in Malnutrition (E63.9: Triglycerides).
Ask our AI Specialists anything about Malnutrition
What Is Malnutrition?
What is malnutrition? Malnutrition means that your body isn't getting enough calories or the right balance of nutrients to stay healthy. This can happen if you don't get enough protein , carbohydrates , and fats , eat too much unhealthy food, or don't get the vitamins and minerals your body needs. Malnutrition can affect people of all ages, but children, older adults, and people with chronic (long-term) health problems have a higher risk. What are the types of malnutrition? Most people think of undernutrition with malnutrition. But malnutrition can refer to undernutrition, overnutrition, or an imbalance of nutrients.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in weight & metabolism, Malnutrition (E63.9) involves adipocyte hypertrophy [Malnutrition E63.9]. Cross-referenced with NIH MeSH (Malnutrition), progression correlates with shifts in HOMA-IR Insulin Resistance in Malnutrition (E63.9: Index) (< 1.4 (E63.9)).
Common Symptoms & Clinical Signs
- • Overnutrition can occur when your body gets too many calories or nutrients. This may lead to obesity or other health issues
- • An unbalanced diet that lacks variety or specific nutrients
- • Presentation of Malnutrition (E63.9): co-existing blood pressure, in Malnutrition (E63.9: triglyceride, or fasting)
- • Secondary Malnutrition clinical sign: joint load discomfort in Malnutrition (E63.9: in knees, hips,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Malnutrition Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | E63.9 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Weight Management & Metabolic Syndrome | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: HOMA-IR Insulin Resistance in Malnutrition (E63.9: Index) | < 1.4 (E63.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: ALT & Fasting in Malnutrition (E63.9: Triglycerides) | ALT < 25 U/L; TG < 100 mg/dL (E63.9) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: DEXA Visceral Adipose in Malnutrition (E63.9: Tissue (VAT)) | < 1.0 lb (< 100 cm2) (E63.9) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Malnutrition
Treatment selection for Malnutrition depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Malnutrition)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Exposure-response analyses of liraglutide 3.0 mg for weight: What a 4,372-Participant Study Found These analyses support the use of liraglutide 3.0 mg for weight management in all subgroups investigated; weight loss increased with higher drug exposure, with no concomitant deterioration in safety/tolerability besides... Diabetes, obesity & metabolism • 2016-05-15 • Phase III Randomized Trial | N = 4,372 | 96/100 | PMID 26833744 ↗ |
| Managing Obesity: Can Effectiveness of testosterone replacement Make a Real Difference? (What New Research Reveals) TRT slightly improved the lean muscle and LDL in men with obesity having LTLs but did not affect the blood pressure. European journal of endocrinology • 2021-12-03 • Meta-Analysis | Multi-cohort | 92/100 | PMID 34738915 ↗ |
| Can This Approach Help? Inside the Latest Research on Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With In Japanese adults with obesity disease, tirzepatide significantly improved HR-QoL over 72 weeks compared with placebo in both physical and psychosocial domains. Diabetes, obesity & metabolism • 2026-08-15 • Phase III Randomized Trial | N = 63 | 88/100 | PMID 42108080 ↗ |
| Can This Approach Help? Inside the Latest Research on Upacicalcet Preserves Albumin Levels in Patients on Hemodialysis with Secondary These findings raise the hypothesis that PTH suppression with upacicalcet mitigates the gradual decline in serum albumin levels over time. American journal of nephrology • 2026-01-15 • Phase III Randomized Trial | N = 99 | 88/100 | PMID 41078042 ↗ |
| Can This Approach Help? Inside the Latest Research on Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Conclusions: Although AI+WL is effective in reversing the hormonal profile of HHG in severely obese men without causing major side effects, it does not lead to greater improvements in muscle strength and symptoms of... Frontiers in endocrinology • 2020-01-15 • Randomized Controlled Trial | N = 12 | 88/100 | PMID 32499757 ↗ |
Malnutrition Patient Community & “People Like Me” Threads
Filter Malnutrition community threads and patient logs by age, biological sex, dosage, and treatment duration.